← Back to Emcure Pharmaceuticals Ltd Overview
📊Financials📈PE Ratio🥧Shareholding💰Dividend📋Quarterly⚖️Balance Sheet💹P&L🌊Cash Flow
EMCUREPharmaceuticals

Emcure Pharmaceuticals Ltd — Financial Ratios & Key Metrics

₹1595.50
+4.14%
P/E Ratio33.89xIndustry: 31.77x
ROE18.51%Return on equity
ROCE20.72%Return on capital
Debt/Equity0.35Low debt
💎

Valuation & Profitability

P/E Ratio
33.89x
Industry Average P/E
31.77x
Dividend Yield
0.21%
Market Cap
₹27.17K (Cr)
Sales Growth 5Y
9.36%
Profit Growth 5Y
36.18%
EPS Growth 5Y
34.92%
OPM 5Y Avg
20.45%
📉

Price Returns

1 Month
+8.73%
3 Months
+5.05%
6 Months
+7.50%
1 Year
+5.06%
52W Low
₹889
Current
₹1596
52W High
₹1672
90% of 52-week range — Near highs
🔬

Technical Indicators

69RSI 14
Neutral
Momentum is balanced — neither overbought nor oversold.
SMA 50
₹1496
▲ Price above SMA 50 — Bullish
SMA 200
₹1407
▲ Long-term uptrend
Volume Signal
318% of avg
Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Emcure Pharmaceuticals Ltd

OverviewFinancialsPE HistoryShareholdingQuarterlyBalance SheetP&LCash FlowPharmaceuticals StocksScreener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.